Cantor Fitzgerald reiterated coverage on Tilray with a new price target

1/7/22 4:42:16 AM ET

Medicinal Chemicals and Botanical Products

Health Care

Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $7.40 from $11.80 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TLRY

Date	Price Target	Rating	Analyst
4/5/2024	$2.25 → $2.75	Neutral	Alliance Global Partners
11/2/2022	$3.90	Mkt Perform	Bernstein
7/29/2022	$3.00	Hold → Sell	The Benchmark Company
3/4/2022	$9.00	Hold → Buy	Canaccord Genuity
1/11/2022	$7.40 → $6.90	Neutral	Cantor Fitzgerald
1/7/2022	$11.80 → $7.40	Neutral	Cantor Fitzgerald
11/18/2021	$10.00	Underweight	Barclays
11/1/2021	$18.00 → $11.80	Overweight → Neutral	Cantor Fitzgerald